Risk factors for developing advanced BCC
An assortment of clinical and pathologic features drives the risk of BCC recurrence.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) identify various features of BCC that correlate with greater likelihood of disease recurrence in patients who initially present with early-stage, localized disease.1
References: 1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Basal Cell Skin Cancer V.2.2021. © National Comprehensive Cancer Network, Inc. 2021. All rights reserved. Accessed August 12, 2021. To view the most recent and complete version of the guidelines, go online to NCCN.org. 2. Data on file. Regeneron Pharmaceuticals, Inc.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.